Quick Answer
Cardio Diagnostics Holdings, Inc. reported Stockholders Equity of $6.97 million for fiscal year 2025.
Cardio Diagnostics Holdings, Inc. Stockholders Equity — Annual History
| Fiscal Year | Stockholders Equity | YoY Change |
|---|---|---|
| 2025 | $6.97M | -27.0% |
| 2024 | $9.56M | +223.1% |
| 2023 | $2.96M | -31.2% |
| 2022 | $4.30M | +302.7% |
| 2021 | $1.07M | +1669.4% |
| 2020 | $60.4K | — |
Quarterly Stockholders Equity
| Quarter Ending | Stockholders Equity | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $8.15M | +121.1% | -16.2% |
| June 30, 2025 | $9.72M | +216.3% | -14.5% |
| March 31, 2025 | $11.38M | +274.6% | +19.0% |
| December 31, 2024 | $9.56M | +223.1% | +159.3% |
| September 30, 2024 | $3.69M | +61.1% | +19.9% |
| June 30, 2024 | $3.07M | +5.7% | +1.2% |
| March 31, 2024 | $3.04M | -11.3% | +2.7% |
| December 31, 2023 | $2.96M | -31.2% | +29.3% |
- Cardio Diagnostics Holdings, Inc. showed a decrease of -27.0% in Stockholders Equity compared to the prior fiscal year.
- Over the 2020–2025 period, Cardio Diagnostics Holdings, Inc.’s stockholders equity has grown by 11452.0% (from $60.4 thousand to $6.97 million).
- The most recent figure is from Cardio Diagnostics Holdings, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 13, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: